AE
AMH Equity’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
3,508,703
+121,348
| +4% | +$53.9K | 2.05% | 19 |
|
|
2025
Q1 | $1.92M | Buy |
3,387,355
+887,355
| +35% | +$502K | 2.89% | 8 |
|
|
2024
Q4 | $5.28M | Buy |
2,500,000
+111,132
| +5% | +$234K | 5.19% | 6 |
|
|
2024
Q3 | $6.43M | Buy |
2,388,868
+188,946
| +9% | +$508K | 8.15% | 3 |
|
|
2024
Q2 | $6.27M | Sell |
2,199,922
-124,278
| -5% | -$354K | 8.31% | 3 |
|
|
2024
Q1 | $9.85M | Buy |
2,324,200
+161,307
| +7% | +$684K | 9.66% | 3 |
|
|
2023
Q4 | $11.6M | Buy |
2,162,893
+21,540
| +1% | +$115K | 10.39% | 2 |
|
|
2023
Q3 | $9.21M | Buy |
2,141,353
+141,353
| +7% | +$608K | 10.12% | 3 |
|
|
2023
Q2 | $11M | Sell |
2,000,000
-53,907
| -3% | -$296K | 12.55% | 2 |
|
|
2023
Q1 | $8.63M | Sell |
2,053,907
-200,000
| -9% | -$840K | 9.89% | 3 |
|
|
2022
Q4 | $6.24M | Buy |
2,253,907
+633,124
| +39% | +$1.75M | 9.26% | 3 |
|
|
2022
Q3 | $4.15M | Buy |
1,620,783
+370,783
| +30% | +$949K | 6.26% | 4 |
|
|
2022
Q2 | $4.5M | Buy |
1,250,000
+473,747
| +61% | +$1.71M | 7.77% | 4 |
|
|
2022
Q1 | $4.82M | Sell |
776,253
-23,747
| -3% | -$147K | 5% | 7 |
|
|
2021
Q4 | $5.64M | Buy |
+800,000
| New | +$5.64M | 7.84% | 6 |
|